Bio-Path Presents Prexigebersen AML Combo Data At EHA 2024
14 Jun 2024 //
GLOBENEWSWIRE
Bio-Path`s Prexigebersen AML Combo Data At ASCO 2024
03 Jun 2024 //
GLOBENEWSWIRE
Bio-Path to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen
24 Oct 2023 //
GLOBENEWSWIRE
Bio-Path Holdings Announces Results from Phase 2 of Prexigebersen
01 Aug 2023 //
GLOBENEWSWIRE
Bio-Path Receives Notice of Allowance for Strategic Patent for Prexigebersen
22 Oct 2020 //
GLOBENEWSWIRE
Bio-Path Holdings Announces First Patient Dosed in Amended St2 of the Ph2 Trial
13 Aug 2020 //
GLOBENEWSWIRE